NEW IPR MODEL DEVELOPED TO AID GENERIC MEDICINE SALES
February 2nd, 2011
BY KEITH NUTHALL
A EUROPEAN Union (EU) research project is trying to develop a new intellectual property rights regime allowing the inventors of medicines to adopt a liberal licence allowing the swift manufacture of generic copies. This Innova-P2 project wants to create, said a European Commission note, "a potential two-tiered patent system that would give innovators a choice." It said those adopting a tailor-made 'Patent-2' licences "would not have veto powers over the reproduction of their inventions". This would enable "medicines ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.